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LIST OF DEFINITIONS 
Antibiotics: Medications that are used to kill bacterial microorganisms. 
Antibiotic containment: The curbed use of antibiotics to reduce antibiotic resistance. 
Antibiotic resistance: This occurs when a bacteria changes to adapt to antibiotics rendering 
the drug not useful. 
Antibiogram:  This is a summary of cumulative proportion of microorganisms that is 
susceptible to particular antibiotics 
Antibiotic stewardship: A synchronized program which promotes the efficacious use of 
antibiotics to prolong shelf life. 
Concurrent antibiotic use: This is the use of more than one antibiotic simultaneously. 
Definitive therapy:  Prescription of antibiotics that is guided by a culture result. 
Empiric therapy: Use of antibiotics that is not guided by a culture result but through 
matching the narrowest spectrum antibiotic to the most likely pathogen.  
Intensive care unit (ICU): Section of the hospital which provide intensive care to the very ill 
patients. 
Prophylactic therapy: Use of antibiotics that is given once off to protect against infection 
normally given prior to certain surgical procedures. 
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ABSTRACT 
Introduction: Antibiotic resistance presents a great challenge as the World Health 
Organization declared antibiotic resistance a global threat. Considering the high disease 
burden, prescribers are pressured to treat empirically rather than definitively especially in the 
intensive care units (ICU) where critically ill patients need rapid treatment. 
Aim: The aim of this study was to document the utilization of antibiotics in a tertiary level 
hospital intensive care unit. 
Method: This was a retrospective record review and data was collected for a two-month 
period in 2016 and 2017. Information was transcribed from the ICU charts. Variables 
included antibiotic chosen, number of antibiotics per patient, duration and frequency of 
treatment as well as information on the microorganisms involved. Data was analysed 
quantitatively using mean, median and frequency. 
Result: The majority (67% in 2016 and 75% in 2017) of patients admitted to the Helen Joseph 
Hospital (HJH) ICU during the study period were on antibiotics and the majority were treated 
empirically. The most frequently used antibiotics were amoxicillin/clavulanic acid followed 
by piperacillin/tazobactam. The majority of antibiotics stocked in the ICU were started on day 
zero of admission compared to the restricted antibiotics. The average antibiotic per patient 
was one and a maximum of three antibiotics was used concurrently. The average length of 
stay in HJH ICU was two days. Klebsiella pneumoniae (17%), Enterobacter cloacae (15%), 
Staphylococcus aureus (11%), Escherichia coli (9%) and Pseudomonas aeruginosa (6%) 
were the frequently most isolated pathogens. 
Conclusion: The study concluded that restriction of antibiotics does improve antibiotic 
utilization. Also the length of stay in the HJH ICU is short. Concurrent use of antibiotics was 
low. Furthermore, there were some antibiotics utilization patterns seen which are not 
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supportive for a successful antibiotic stewardship. If there are no interventions informed by 
utilization studies, same patterns will continue. 
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CHAPTER 1: INTRODUCTION 
This chapter is structured to understand the impending threat of antibiotic resistance and the 
impact of utilization of antibiotics in the intensive care unit (ICU). It also highlights the 
factors which have fuelled the rise in the global microorganism resistance. This chapter 
concludes with an outline of the problem statement, research question as well as the aim and 
objectives of the study. 
1.1. Background 
The rapid development of antibiotics in the past century has meant that infectious diseases 
that once had high mortality and morbidity rates are treatable with antibiotics with a high 
success rates (Davies, 2007; Lau et al., 2004; Pignatari and Myake, 2015). In developing 
countries like South Africa, where levels of poverty are high, antibiotics have effectively been 
able to reduce the morbidity and mortality of poverty influenced infections (Ventola, 2015).  
Globally antibiotic consumption rose by 36% between the years 2000 and 2010 (Meyer and 
Sibanda, 2016). In South Africa the use of antibiotics increased with population growth 
between the years 2000 and 2010 (O‟Neill, 2014). Also, lack of regulation of antibiotics, 
convenient availability as well as the ability to cure infections have made antibiotics an easy 
choice and this have further increased over consumption (Ventola, 2015). 
In the last ten years the increase in both the capacity and number value of multiresistant 
organisms has become a global health issue (Roca et al., 2015). The excessive use of 
antibiotics which includes over prescribing, long duration of antibiotic use and wrong choice 
of antibiotics has led to the increase of resistant strains (Edgar et al., 2008; Essack, 2006; 
Farrell, 2009; Mabila et al., 2016; Messina et al., 2017). Multidrug resistant microorganisms, 
which are only sensitive to the last-line and older more toxic antibiotics like colistin, are on 
the rise (O‟Neill, 2014).  
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The ICUs of the hospitals admit the critically sick and the use of multiple antibiotics in these 
units for fear of not knowing which antibiotics will work has further disadvantaged the fight 
against antibiotic resistance (Thomas et al., 2015; Paruk et al., 2012). Moreover, in the ICUs, 
antibiotic stewardship intervention like de-escalation to narrower spectrum antibiotics when 
culture results are received is not generally practiced. Also, failure to stop previous antibiotics 
before starting a new one has further led to patients admitted in the ICU receiving multiple 
antibiotics (Thomas et al., 2015; Paruk et al., 2012).  
A study which looked at the use of antibiotics in the ICU of hospitals including the public and 
private sector in five different provinces noted that antibiotics were prescribed to more than 
50% of the patients and in these patients, 72% received it for an inappropriate duration (Paruk 
et al., 2012). Antibiotics are prescribed to 44-97% of the patients admitted to hospital and are 
mostly unnecessary in a developing country like South Africa (Hadi et al., 2008). In South 
Africa, a study showed the prevalence of inappropriate antibiotic prescription practices to be 
60% in the private sector and 40% in the public sector (Paruk et al., 2012). Factors that have 
been noted to pressure the physicians‟ decision to irrationally prescribe antibiotics include 
patient demands, uncertainty as to which patients would gain from antimicrobial therapy, 
daily pressures from clinical practice, patient complaints, physical observation, control of 
disease, physicians‟ self-confidence and the daily pressures from varying policies and 
research discoveries (Sosa and Travers, 2002; Simpson et al., 2007). 
The burden of antibiotic resistance impacts widely on certain clinical and economical 
outcomes of the patients and society. These consequences may include increased length of 
hospital stay, adverse events, and cost to the hospital, patient and society (Zilahi et al., 2016). 
Furthermore, failure of an antibiotic leads to the usage of costlier substitutes which places an 
increased burden on the financial growth of the economy (Essack, 2006). In South Africa, 
microorganisms especially the Gram-negative microbes which are multi-resistant to 
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antibiotics are a great health problem and are increasing the toll of human mortality and 
morbidity (Brink et al., 2012; Davies, 2007; Paruk et al., 2012; Zhang et al., 2006).  
The use and abuse of antibiotics have raised antibiotics resistance to one of the greatest health 
problems. It is envisaged that one in three people will die from a multidrug resistant causing 
disease by 2050 (O‟Neill, 2014). The slide to the pre-antibiotic era where there were no 
antibiotics will affect new medical progress. New technological improvements like transplants 
and chemotherapy will be made impossible due to the lack of effective choice of antibiotics 
(Gillon and Wyncol; 2016, Messina et al., 2017). 
Additionally, the rise of antibiotic resistance strains has not been matched by an increase in 
the discovery of original antibiotics. The past thirty years have seen a decrease in new 
antibiotics. If antibiotic usage together with the development of resistance is not monitored, 
this will lead back to the era where there were no antibiotics. Fewer antibiotics in the pipeline 
and low efficacy due to resistance of available antibiotic are factors burdening the health 
system (Adeniji, 2017; Lee et al., 2013; Mabila et al., 2016).  
Considering the different resistance patterns seen across countries, individual country 
strategies to improve and continue the therapeutic benefits of antibiotics are necessary 
(Chaudhry and Prajapat, 2017). The prevalence of infections in the South African (PISA) 
ICUs reported in the study done by Paruk et al., (2012) affirmed strongly to reduce the 
emergence of antimicrobial resistance and recommendations were published which included 
advising prescribers on the correct empirical choice, dosing methods, de-escalation and 
duration of treatment. 
The principles of antibiotic stewardship include the surveillance of antibiotic use, improved 
antibiotic policies and management as well as antibiotic management programmes. The main 
aim of antibiotic stewardship is to improve the use of antibiotics through appropriate controls 
which includes choice of antibiotics, de-escalation, education and continuous antibiotics 
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usage monitoring (Richards, 2016; Boyles et al., 2013). Pharmacist critical evaluation of 
prescriptions by checking basic antibiotic stewardship principles for example if cultures was 
sent before dosing antibiotics, duration of treatment, checking for accurate dosing, double 
antibiotic coverage, if antibiotic is prescribed empirically, definitively or prophylactically will 
improve and save the efficacy of antibiotics for the future (Boyles et al.,2013). A study done 
in South Africa showed a decrease in overall consumption of antibiotics after starting routine 
ward rounds done by pharmacists. Through the help of antibiotic stewardship programs, 
global consumption of antibiotics has been reported to be reduced by 22-36% (Vitrat et al., 
2014). A stewardship program implemented in a hospital showed that restricting 
cephalosporin use decreased the development of resistant Klebsiella species. Remarkably in 
the same study, the use of imipenem/cilastatin increased by 141% during the same period 
which then increased the number of resistant Pseudomonas aeruginosa (Vitrat et al., 2014). 
Even though there are no randomized controlled trials that have measured the clinical impact 
of antibiotic stewardship intervention like de- escalation in critically ill patients, various 
antibiotic stewardship programs have decreased antibiotic consumption and improved use of 
antibiotics by applying basic antibiotic stewardship principles (Boyles, 2013; Vitrat et al., 
2014). 
To prolong the life span of the antibiotics available, antibiotic stewardship plays an important 
role. Monitoring antibiotic use and changes in resistance patterns is a key to understanding the 
underlying mechanisms by which resistance develops, persists and disseminates. If 
prescribing patterns are not monitored and kept under surveillance, more deadly diseases will 
arise from multidrug-resistant strains of microorganisms (Mabila et al., 2016; Masterton, 
2008; Yeo, 2016). Thus, there is a paramount need for studies to review prescribing practices.  
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1.2. Problem Statement 
The global rise in resistance to antibiotics has made antibiotics, which are some of the most 
important drugs ever discovered, to be relatively ineffective. To prolong the efficacy of 
antibiotics, utilization of antibiotics needs to be measured and understood to ensure 
institutionalised evidence-based systems to curb the global problem of resistance. Resistant 
pathogens distributions vary greatly (Sulaiman, 2016). To date, there is little information on 
antibiotic prescription patterns especially in the ICUs of the public and private sector in South 
Africa (Paruk et al., 2012).  
Even with an abundance of research published worldwide on the usage of antibiotic in the 
ICU, there is a need for antibiotic utilization research in South Africa to monitor specific 
prescribing patterns. This information will guide local strategies, hence the relevance of this 
study to generate usage pattern data as per World Health Organization guidelines as an 
indicator for antimicrobial use. 
 
1.3. Research Question 
How were antibiotics used in the ICU at Helen Joseph Hospital across two-time periods 
without any intervention? 
 
1.4.  Aims and Objectives 
The aim of this study was to determine the utilization of antibiotics in the ICU at Helen 
Joseph hospital. 
To achieve the above aim, the following objectives were outlined: 
1. Document which antibiotics are prescribed, their dosing frequency and duration of use 
as well as the number of antibiotics used per patient. 
 
 
6 
 
2. Record if antibiotics were prescribed empirically, prophylactically or definitively.   
3. Document the microorganisms isolated. 
4. Compare the utilization of antibiotics in the ICU between the two months (2016 and 
2017).  
 
1.5. Summary 
The discovery of antibiotics was one of the marvels of medical discoveries, but the misuse of 
this miracle drug has compromised its place in the treatment of infections and diseases. In 
South Africa, which is further disadvantaged economically, antibiotic resistance will cause 
worse health outcomes to patients and the society. Pharmacists and other health professionals 
can play important roles in the usage of antibiotics and hence can improve prudent use. 
Important strategies based on drug utilization studies helps to inform appropriate policies to 
prolong the life span of antibiotics. 
The next chapter is the literature review. 
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CHAPTER 2 LITERATURE REVIEW 
2.1.  Introduction 
This section draws attention to the utilization of antibiotics and antibiotic resistance as it 
affects the ICU and the world. This chapter also highlights antibiotic resistance, its prevalence 
and mechanisms of resistance and dissemination. The different strategies employed globally 
and in South Africa through surveillance and antibiotic stewardship are further discussed here.  
 
2.2.  Infections and infectious disease burden 
Infectious diseases cause 57 million annual deaths in a global population of 6.2 billion 
(Wheelis, 2011). In addition to established infections, developing and re-emerging infections 
have caused global concern. Presenting a threat presently are not only the new evolving 
diseases but also diseases thought to have been curbed and these organisms are becoming 
more virulent. The epidemics of present and previously named infectious diseases that 
intermittently emerge worsen the global problem of infections (Kombe and Darrow, 2001; 
Ventola, 2015). 
Patients admitted in the ICU possibly develop infection due to the conditions why they are 
admitted in the ICU, immune compromised health status due to critical illness and invasive 
procedures which are common in the ICU (Vincent et al., 2016). Health care facilities 
particularly the ICU remain an important location for the development of antimicrobial 
resistance (Kollef, 2001). 
However, since selective pressure may occur, failure in infection control will allow for 
dissemination of resistant bacteria. Though the effective use of antibiotics with better 
infection control strategies informed by adequate utilization and surveillance studies through 
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antibiotic stewardship can be successful in treating numerous infections (Arbee et al., 2012; 
Essack et al.,2005; Mabila et al., 2016) 
2.2.1.  Diagnosis of infections 
The diagnosis of infection in the critical ill can be challenging due to the impact of the illness 
on pharmacokinetics and pharmacodynamics parameters, lack of confirmatory result and 
immunosuppression from critical illness (Vincent et al., 2016). However, a timeous culture 
result for patients admitted to the ICU is important as this will allow for the correct choice of 
antibiotic therapy (Vincent et al., 2016).  
A raise in temperature and white blood cell counts which are typical signs of infections are 
not specific and can occur in other condition of people that are critically ill. In the absence of 
cultures within the first day, clinicians use infection markers to diagnose the presence of an 
infection (Markanday, 2015; Vincent et al., 2016). 
Biomarkers are a group of protein that react to inflammation and injury by increasing or 
decreasing in concentration. C-reactive protein (CRP), erythrocyte sedimentation rate (ESR), 
procalcitonin (PCT) are some important biomarkers which are used by clinicians to establish 
infections in patients (Markanday, 2015). This group of proteins respond to inflammation and 
injury to different degrees for example the CRP can increase a few thousand fold while the 
ceruloplasmin levels rise 25%-50% and the fibrinogen levels rise only a small amount 
(Markanday, 2015). 
The CRP levels are better than the ESR levels as it is an improved measure of acute phase 
response as well being more sensitive to inflammation. The PCT may also be more useful 
since it more specific for example it does not rise in non-infectious inflammatory conditions 
e.g. gout and arthritis. However, there have been reports in the literature of transient rises in 
procalcitonin in massive trauma like burns and surgery. New technologies have also improved 
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assays where results can be obtained in thirty minutes or less (Gilbert, 2011; Markanday, 
2015; Simon et al., 2004). 
 
 2.3. Antibiotic usage in the ICU 
The ICU accommodates patients who have critical medical problems and are housed in a 
small restricted area. Dissemination of bacteria and emergence of resistance is exacerbated 
due to overcrowded nature of the area, reduced nursing staff due to economic burden, 
increased critically ill patients who are admitted for a longer periods and overuse of 
antibiotics (Kollef, 2001; Sarin et al., 2013). The widespread use of antibiotics to reduce and 
cure infection has made antibiotics the most frequently prescribed drug in the ICU (Kolak, 
2010; Perekoa et al., 2015). Decisions for prescribing antibiotics are mostly empiric and 
based on behavioural pressure and experience (Sarin et al., 2013; Williams et al., 2011) 
Antibiotic resistance seen in the ICU is increasing the global public health threat by 
increasing the mortality and morbidity of patients being treated with antibiotics (Chaudhry 
and Prajapat, 2017). Even though the ICU houses a small number of patients, antibiotics are 
used in larger numbers as clinicians are pressured to prescribe antibiotics because patients are 
very ill and often colonized with difficult to treat pathogens (Kollef, 2001). Also, the change 
in pharmacokinetics of the critically ill patients plays a factor hence monitoring and 
optimizing antibiotic usage in the ICU is advantageous (Calbo and Garau, 2005). 
Therefore, adequate monitoring and regulation of antibiotic usage, regional surveillance 
which should include the ICU is necessary to contain the growing burden of antibiotic 
resistance and contain the limited antibiotics available (Chaudhry and Prajapat, 2017; 
Chunnilall et al., 2015; Gillon and Wyncoll, 2016). 
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2.4. Antibiotic resistance  
Antibiotic resistance is a situation where the microorganism changes in some way to survive 
the prevailing conditions despite the presence of antibiotics. Resistant pathogens continue to 
regrow and regenerate in the presence of adequate therapeutic dose of antibiotics (Van Wyk, 
2015). The increase in antimicrobial resistance is seen in the ICUs due to the exposure to 
numerous broad-spectrum antibiotics. Hence the incidence of culturing multidrug resistant 
strains is usually higher in the ICUs compared to other wards in the hospital and this has 
created a huge burden (Chastre, 2008; Sarin et al., 2013).  
The 20th and the 21st century have experienced treatment failure of antibiotics due to 
increasing burden of antibiotic resistance all over the world especially in the ICUs (Lee et al., 
2013). Today, methicillin-resistant Staphylococci aureus (MRSA) is prevalent around the 
world. MRSA which was once present only in the ICUs of the hospital have moved into 
communities thereby becoming even more transmissible and hence a reason for concern 
(Bloomfields, 2006). A study by Lodise et al, (2002) compared the outcome of infections 
caused by very resistant enterococcus (VRE) to the susceptible strain and demonstrated that 
VRE affects treatment outcomes negatively. 
A primary function of bacteria is to become more complex to ensure survival (Van Wyk, 
2015). The use of efflux pumps, production of enzymes, genetic alteration and development 
of alternative pathways are some mechanisms which microorganisms utilize to become 
resistant (Van Wyk, 2015). 
2.4.1. Risk factors driving antibiotic resistance  
A variation in patient characteristics, hospital procedures and environmental setting creates a 
risk factor in the development of resistant pathogens in the hospital. In the hospital setting, 
factors such as dialysis, intensive care stay, mechanical ventilation, urinary catheterisation, 
previous and current antibiotic therapy, venous and peripheral catheters, previous 
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hospitalization, wounds, immune compromised therapy, comorbidities, severity of illness and 
surgery have been reported as risk factors for the development of resistant pathogens (Essack, 
2006). 
2.4.2. Antibiotic use and selection pressure 
Selection pressure refers to the condition that allows certain organisms with certain 
characteristics to survive. When microorganisms are exposed to antibiotics, susceptible 
populations are eradicated leaving the resistant strain to replicate passing on genetic material 
to offspring (Essack, 2006). Antibiotic use is the key factor driving selection pressure (Tello 
et al., 2012) 
Evidence in the literature links the inappropriate use of antibiotics to the increase of resistance 
with resistant strains prevalent in wards where antibiotics are used in large doses such as the 
intensive care (Perekoa et al., 2015; Zilahi et al., 2016). However, the linkage of the overuse 
of antibiotics to the increase in antibiotic resistance is complex and controversial. Although it 
is generally accepted that reducing the use of antibiotics and increasing prudent prescribing 
would reduce selection pressure which leads to the increase in antibiotic resistant strains 
(Tello et al., 2012; Zilahi et al., 2016).  
2.4.3 Pharmacodynamics, pharmacokinetics and clinical efficacy 
Pharmacodynamics refers to the relationship between the quantity of drug in the cell tissue, 
the toxicity and the effect reached at the site of action (Grau et al., 2007). Pharmacokinetic 
characteristics refer to the absorption, distribution and elimination of the antibiotics. These 
properties regulate antibiotics access through different cell barriers, their effect against 
microorganisms, hepatic and renal clearance and their higher or lower distribution properties 
which are important in critically ill patients admitted in the ICU (Grau et al., 2007).  
The clinical efficacy of antibiotic therapy is achieved in its adequate concentration in the 
plasma to achieve adequate therapeutic levels. In the clinically ill who are in the ICU, the 
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recommended therapeutic level may not be adequate due to fluid shifts, including the opening 
of extracorporeal circuits which alters the volume of distribution. This predisposes further to 
microorganism resistance due to sub therapeutic levels of antibiotics (Gillon and Wyncoll, 
2016; Alexander et al., 2008). Hence knowledge of the pharmacodynamics and 
pharmacokinetics properties of antibiotics is important to guide adequate antibiotic choice and 
dosing (Levison and Levison, 2009). 
 
2.5. Antibiotic utilization patterns 
Since the rise of antibiotic use is linked to the increase in antibiotic resistance, reviewing 
antibiotic utilization patterns is important (Meher et al., 2014). The true impact of antibiotic 
resistance and its effect on the health outcome of the patients is not properly understood hence 
the prescription pattern of antibiotics needs to be known and compared to data from other 
parts of the world (Truter, 2015).  
The PISA study which looked at the utilization of antibiotics in South African ICUs 
demonstrated that average antibiotic per prescription was three (Paruk et al.,2012) while 
another study done in an ICU in India by Anand et al., (2016) demonstrated 1.73 antibiotics 
per prescription. Comparing the different types of antibiotics utilized, a study done by Ansari, 
(2001) studied the utilization of antibiotics in the different wards of a teaching hospital in Iran 
where ampicillin, cefazolin, ceftizoxime, gentamicin, and cephalexin was the most frequently 
used antibiotics. In a study in another university teaching hospital in Iran by Ebrahimzadeh et 
al., (2008), the most commonly used antibiotics was cefazolin followed by ampicillin, 
ceftizoxime and gentamicin. In both the studies, the ICU featured among the wards which 
used antibiotics the most. An antibiotic utilization study done in South Africa in retail 
pharmacies across the country reported that beta-lactam antibiotics were the most frequently 
prescribed antibiotics followed by antivirals and then fluoroquinolones (Truter, 2015). The 
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different measures of antibiotic use as they relate to antibiotic resistance is important 
knowledge as it ensures better interventions are made (Schellack et al., 2017). 
 
2.6. Initialisation of antibiotic therapy 
Empirical antibiotic treatment is the use of an antibiotic which is not guided by a culture 
result and based on experience while definitive antibiotic therapy is a therapy guided by a 
culture result. Prophylactic use of antibiotic is the use of antibiotics to prevent anticipated 
infection. Culture results from the laboratory are usually not available within 24-48 hours of 
admission and withholding antibiotics from the critically ill patient raises mortality and 
morbidity rates. Empiric use and choice of antibiotics which is informed by the hospital 
antibiogram to cover suspected microorganism offers a safer health outcome in patients 
(Leekha et al., 2011). Different to this thought, the time for initiation of antibiotics will 
require a complex consideration if to start antibiotics immediately after cultures are taken 
(aggressive option) or after infection is confirmed (conservative option). The aggressive route 
of starting antibiotics as soon as cultures are obtained will lead to unnecessary and long 
duration of antibiotic use. However, the second more conservative route might lead to harmful 
delay of antibiotics (Hranjec et al., 2012). Notably, a study done by Hranjec and Sawyer, 
(2014) found that in normotensive patient with suspected infection, waiting to secure results 
which confirms infection reduced mortality in comparison with the aggressive way of starting 
antibiotics on suspicion of an infection (Hranjec et al., 2012). The challenge of treating the 
very sick patients in the ICU leads to the overuse of antibiotics empirically rather than 
definitively.  
While some diagnoses require immediate use of antibiotics, some diagnoses can await a 
culture result. Initiating empiric antibiotic choice in certain diagnoses such as sepsis and 
febrile neutropenia should be immediate. However, in diagnoses such as endocarditis and 
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osteomyelitis, where the patient may have been ill for many weeks, antibiotic treatment can 
be withheld until several blood cultures have been received. In these cases, early initiation of 
antibiotics can suppress microorganism growth and reduce the chances of finding the right 
diagnosis (Leekha et al., 2011) 
 
2.7. Duration of antibiotic therapy 
Duration of antibiotics is important as it is linked to increased emergence of antibiotic 
resistance, adverse effects and overall cost to the health system (Zilahi et al., 2016). The ideal 
duration of antibiotic is still not understood adequately as there is no randomized controlled 
data supporting this view due to ethical reasons (Havey et al., 2013). The length of antibiotics 
used in the critically ill with bloodstream infections is often different in various scenarios but 
frequently extended (Havey et al, 2013). A study done by Chin et al., (2010) reported that the 
duration of antibiotics varied from 1-42 days. 
The best way to reduce overuse of antibiotics is to discontinue antibiotics when no longer 
required using blood cultures with clinical progress, keeping the antibiotic course as short as 
possible and not starting antibiotics when not essential for example when treating colonization 
(Zilahi et al., 2016). A microbiological result alone does not justify elongated duration of 
antibiotics therapy because clinical cure does not necessarily mean microorganism abolition. 
The use of biomarkers may be used when deciding on the appropriate duration for antibiotics, 
but they should be interpreted thoughtfully (Zilahi et al., 2016). 
A study done by Chastre et al., (2003) compared two durations of antibiotic therapy in the 
treatment of ventilated acquired pneumonia. When comparing the recurrence of ventilated 
acquired pneumonia in patients treated with antibiotics for eight days and 15 days, the 
frequency of recurrence of pulmonary infections by resistant microorganism from patients 
treated for eight days was less than those patients treated for longer periods. One of the 
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various advantages of reducing the duration of antibiotics is the decrease in selective pressure 
for resistant pathogens (Puskarich et al., 2011).  
There are certain situations where a long duration of antibiotic therapy is beneficial. There is 
evidence that long duration of antibiotics is indicated for treatment of infective endocarditis, 
Legionella pneumonia, osteomyelitis and fungal infections however, long duration of 
treatment with antibiotics predisposes for antibiotic resistance and adverse effect of the 
medication (Lawrence and Kollef, 2009). There is an increasing indication from the literature 
that reduction in the duration of the course of antibiotics in the ICU can thus reduce the 
negative effects of antibiotic overuse (Zilahi et al., 2016). 
 
2.8. Surveillance 
Surveillance as defined by Pittet (2005) „is an on-going, systematic, collection, analysis and 
interpretation of data essential for planning, implementation and evaluation of public health 
practices which is closely integrated with the timeous dissemination of data to the necessary 
parties‟. In recent times it has been more inclusively defined by Meyer and Sibanda (2016) as 
„a multidisciplinary systemic approach to optimising the appropriate use of all antimicrobials 
to improve patient outcome and limit the development of resistant pathogens while ensuring 
patient safety‟. 
Surveillance is fundamental to any antibiotic resistance strategy providing information 
required through data from drug utilization studies to trace and monitor an antibiotic 
resistance problem (Meyer and Sibanda, 2016; Smith and Coast, 2002). Thus the objective of 
surveillance is to facilitate the containment of antibiotic resistance by informing different 
strategies necessary to improve rational prescribing (rational drug use, reduction in the 
duration of therapy, dosing regimen using the pharmacodynamics and pharmacokinetics) of 
the particular population, implementation of infection control policies and procedures and the 
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amendment to standard treatment guidelines following data collected (Essack, 2006; Johnson, 
2015; Pittet,2005).  
Several surveillance programs have been developed for a precise goal, for example, in 
Germany, the surveillance of antibiotic use and bacterial resistance in ICUs (SARI) has been 
designed to find a connection between antibiotic use in the ICU and the emergence of 
antibiotic resistance (Meyer et al., 2006). Even though establishing antibiotic use and the 
development of resistance is complex, the prudent use of antibiotics in the ICU should be 
promoted to reduce resistant pathogens (Meyer et al., 2006). 
More recently, South Africa has also joined the international call by the WHO to reduce 
antibiotic resistance with a more national approach with the South African Antibiotic 
Stewardship Program (SAASP). This program has increased the knowledge of antibiotics use 
and put in place systems and guidelines to improve appropriate and judicious antibiotic use 
through harmonization of antibiotic guidelines, education, engaging in economic dialogue 
with the stakeholders and strengthening antibiotic stewardship in the public and private health 
sector (Fidssa.co.za, 2018)  
In South Africa, a surveillance study was set up in KwaZulu-Natal to appraise the 
appropriateness of the standard treatment guidelines and the essential drug list in the public 
health system. Resistance profiles ranged from 14-100% with the district having more 
susceptible microorganisms than the tertiary hospitals. The study resolved that the standard 
treatment guidelines are not ideal for adequate therapeutic outcome as the resistance in the 
different hospitals varies widely (Essack et al., 2005; Essack, 2006). The developed world has 
shown progress to international surveillance policies which is aimed at improving prudent 
antibiotic use, however, the developing countries like South Africa are still yet to attain a co-
ordinated surveillance system (Chaudhary, 2016). 
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Furthermore, since resistant pathogen distributions vary differently and following sensitivity 
pattern from other regions will not be as effective, surveillance studies are needed in South 
Africa to monitor zone resistance patterns, guide local empirical therapy and to implement 
timely and adequate countermeasures (Chaudhry and Prajapat, 2017; Roukens et al., 2017).  
 
2.9. Antibiotic Stewardship 
The first definition of antibiotic stewardship emanated in the 1997 as a systematic collection 
of strategies, guidelines, policies and tools to improve the prescribing of antibiotics to reduce 
resistance and improve rational use (Howard et al., 2015). 
The ICU uses antibiotics frequently and hence presents an ideal arena to rollout and monitor 
antibiotic stewardship strategies (Howard et al., 2015). In South Africa, irrational and lack of 
cautious prescribing which includes the use of broad-spectrum antibiotics, the use of a 
combination of antibiotics and prolonged duration of therapy has further driven the 
emergence and dissemination of multidrug resistant bacteria in the ICU. This is clearly seen in 
the ICUs where even up to ten antibiotics are given concurrently (Ramsamy et al., 2013, 
Paruk et al., 2012).  
The role of antibiotic stewardship is in the preventing and reducing the emergence of resistant 
microorganism, the reduction of antibiotic side effect and cost effective antibiotic usage. As 
new antibiotics that are effective might only be available in the next one to two decades, the 
onus is on every health practitioner to challenge irrational prescribing practices (Brink et al., 
2012; Kaki et al., 2011). The most important ways of curbing antibiotic resistance are the use 
of policies which are informed by local antibiogram patterns which will then allow the 
effective choice of an empiric therapy and effective antibiotic stewardship (Ramsamy et al., 
2013). 
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2.9.1 Antibiotic stewardship intervention by pharmacist to improve antibiotic use   
Pharmacists are the safe custodian of medicines and have impacted positively on good 
antibiotic stewardship. Stewardship development plans made by pharmacists can reduce 
antibiotic consumption, improve surgical site prophylaxis guideline adherence and improve 
antibiotic rational use and therapeutic monitoring of many antibiotics (Boyles et al., 2013). 
Antibiotic Stewardship initiative and implementation takes a multidisciplinary team to 
achieve a positive impact (Boyles et al., 2013; Kubin, 2011). Although in South Africa, 
clinical pharmacy is still in its early stages and faces various challenges, there is evidence that 
pharmacist-initiated intervention improves utilization of antibiotics. Pharmacist-initiated 
intervention to ensure appropriate use of antibiotics are seen in the studies done by Somai et 
al., (2014), Zhou et al., (2015) and in South Africa by Boyles et al., (2013) were able to 
reduce antibiotic consumption and improve utilization. 
 
2.10. Summary 
The ICU hospitalizes the critically ill and this may lead to the excessive use of antibiotics and 
often inappropriate. Factors like not knowing how severe the microorganism causing the 
illness is pressure clinicians to prescribe antibiotics even when not necessary. This has fuelled 
the growth of antibiotic resistance in the intensive care unit. Information from drug utilization 
and surveillance studies has been used to successfully improve the utilization of antibiotics in 
hospitals. Antibiotic resistance shows regional differences so a blanket approach of using 
another countries antibiogram to choose or decide on the antibiotics usage in this country will 
be not be effective. South Africa has antibiotic stewardship rolled out in hospitals but 
synchronized information and strategies for curbing antimicrobial resistance is still a 
challenge. The interventions made by clinical pharmacist have shown successful improvement 
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in the compliance to appropriate antibiotic use. The next chapter is the methodology where 
the process and procedure followed for this study is stipulated. 
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CHAPTER 3 – METHODOLOGY 
3.1. Introduction 
This chapter is the methodology and explains the procedure followed in this study. It includes 
the study design, sampling, data sources, data collection, description of data collection tool, 
explanation of the process in issuing antibiotics to the wards, statistical analyses and ethical 
considerations.  
 
3.2. Study design, setting and population 
This was a sub study of a larger study to review the usage of antibiotics in the different public 
hospitals in Gauteng (Appendix 1). It was a retrospective record review which was conducted 
in the ICU of Helen Joseph Academic Tertiary Hospital (HJH) from 15th January 2016 to 
15th of February 2016 and from 15th of January 2017 till the 15th of February 2017. These 
times was chosen across both years to ascertain if there were similarities with antibiotic 
utilization without any intervention been implemented. 
HJH is a provincial tertiary level hospital in Auckland Park, Johannesburg. The hospital has 
616 beds in total. The ICU is a ten-bedded unit and admits approximately ten patients per 
week.  
This study included critically ill patients who were admitted straight to ICU or transferred 
from other wards to the ICU and who met the inclusion criteria. The ICU charts of patients 
admitted during the study periods were all analysed.  
 
3.3. Sampling 
All the ICU files of patients admitted within the stipulated study period were analysed. The 
exclusion criteria included: 
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  Patients below the age of eighteen. 
  Patients whose ICU chart was not found 
  Patients who had incomplete information on their ICU charts and this  
 missing information could not be tracked on LABTRAK  
 
3.4. Data sources 
The ICU charts are used in the unit to document patient information, diagnosis, medications 
and interventions made by healthcare professionals. The chart contains patient information 
relating to the antibiotics prescribed, diagnosis, doctors notes and laboratory tests ordered.  
Information relating to cultures and infection markers is frequently documented on the ICU 
chart. When information relating to laboratory tests was not found on the chart, it was 
accessed on the LABTRAK system. The LABTRAK system is the software which is used by 
the provincial hospital to receive patient results and communication from the National Health 
Laboratory services (NHLS).  
 
3.5. Data collection 
Data collection was for the two months and included all patients that were admitted in the 
ICU from the period of 15th January 2016 to 15th of February 2016 and from the 15th 
January 2017 to the 15th February 2017. All patients‟ ICU charts admitted in the study 
periods were pulled from archives in the records and filing department of HJH. Data was then 
collected and recorded using a modified version of the South African Antibiotic Stewardship 
Program (SAASP) antibiotic prescription form (Appendix 2).  
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The NHLS LABTRAK barcode stock on the patient‟s ICU charts was used to track the 
microbiology results. Alternatively, the patients‟ hospital number and/or surname was used to 
get required information from the software. 
 
3.6. Data collection tool 
The ICU chart records all the information that is necessary when prescribing antibiotics. 
Using this as a data collection tool allowed the researchers to collect information on antibiotic 
use from the ICU charts. The South African Stewardship Program Antibiotic (SAASP) form 
was amended by removing patient names and date of birth to maintain confidentiality. The 
variables which were documented for each patient are included in Table 1 below. 
Table 1: Description of variables 
Variables Description 
Study number  Allocated by the researcher to maintain confidentiality. 
Demographics  Gender and age 
Usage of antibiotics  Doses, strengths, frequency and route of administration 
of all antibiotics prescribed. 
Date of admission and date of 
discharge 
The date of admission and date of discharge from the 
ICU per patient was used to calculate the average length 
of stay. 
Microorganisms and sensitivities 
cultured  
To ascertain sensitivity patterns of isolated 
microorganisms 
Infection markers ordered To determine the frequency in which infections markers 
were ordered  
Diagnosis indicated Diagnosis documented on the ICU chart  
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3.7. Process of antibiotic issue in Helen Joseph 
Figure 1 explains the process followed when stock is ordered from the ICU. 
Figure 1: Process followed when antibiotics are issued in HJH 
 
3.8. Statistical Analyses 
The variables collected using the data collection tool (Appendix 2) were captured on a 
Microsoft Excel version 14.0.6112.5000 spread sheet and analysed using Stata/IC version 
14.1. Descriptive statistics including means and medians with standard deviations and inter-
quartile ranges (IQR) were calculated. The Shapiro-Wilk test was used to determine whether 
the variables followed a normal distribution. The variables which followed a normal 
distribution are reported using the mean (±SD) and the variable that did not follow a normal 
distribution are expressed as median (interquartile range) and frequency (Cagan et al., 2017). 
The Kruskal Wallis test was used to assess the statistical difference in the median number of 
days and on what decision the choice of antibiotics was based (Dalgaard, 2008). 
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3.9. Ethical consideration 
Hospital approval to conduct this study was attained (Appendix 3). Ethics approval from 
Human Research Ethics Committee (Medical) of the University of the Witwatersrand was 
granted (M170395). Study numbers were allocated to patient files. No dates of birth or patient 
names were recorded on the collection tool. An information data sheet which correlated study 
number to patient name and birth date was accessible to only the researcher and the 
supervisors. This information sheet was locked away in a secured cupboard for five years. 
Anonymity and confidentially of the patients was maintained throughout the study. 
Clinicians‟ details were not recorded. 
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CHAPTER 4:  RESULTS 
4.1. Introduction 
 This chapter analyses the result from the study carried out in the ICU of HJH. Issue of 
antibiotics to the ICU, files excluded/missing files, demographics, length of stay in the ICU, 
antibiotic use in the ICU, culture and sensitivity testing, infection markers are headings used 
to report this chapter.  
 
4.2. Excluded and missing files 
A total of 60 and 61 patients were recorded on the ICU admission book for 2016 and 2017 
study periods respectively. There were a few ICU patient files which were excluded in 2016 
(n=3) and 2017 (n=2). Files were excluded if the information within the file was incomplete 
or if the patient was under the age of 18 years. There were eleven files in 2016 and eight files 
2017 which could not be located. The total number of files included in the study periods 
therefore was 46 for 2016 and 51 for 2017. 
 
4.3. Demographics 
Table 2 summarizes the demographic data of the patients in the ICU for the two years. The 
age in the two study periods was normally distributed. The average age was 42 years in both 
2016 and 2017. However, the biggest single group of patients were between 30 and 39 years 
(Figure 2). In 2016, the ICU had 8.7% more females admitted than males. In contrast there 
were 13.7 % more males than females admitted in 2017. 
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Table 2: Demographic data for the two study periods 
Variables 2016  
(n=46) 
2017  
(n=51) 
Age, years mean (SD) 41.9 (16.50) 42.9 (18.18) 
Female, n (%) 25 (54.3) 22 (43.1) 
Male, n (%) 21 (45.75) 29 (56.9) 
 
    
a. (Histogram of patient age in 2016 study period) 
   
 b. (Histogram of patient age in who, study period) 
Figure 2: Histogram of patient age in (a) 2016 and (b) 2017 in years 
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4.4. Diagnosis recorded on the ICU chart 
The primary diagnosis necessitating an ICU admission as documented on the ICU chart is 
summarised in Table 3. The recorded diagnosis on the ICU chart for the majority of the 
patients was the initial diagnosis for which the patient was admitted into the ICU. These 
diagnoses most often do not relate to the reason for antibiotics been used in these patients.  
From this retrospective study carried out in HJH ICU only 20% (n=9) of the charts in 2016 
and 12% (n=6) in 2017 recorded diagnosis which were related to the antibiotic use. No 
diagnosis was recorded in the ICU chart for 9% (n=4) in 2016 and 6% (n=3) in 2017.  
Table 3: Primary diagnosis recorded on the ICU charts for 2016  
Diagnosis as recorded on the ICU charts 2016  
(n=42) 
2017 
(n=48)  
Sepsis 8 4 
Post laparotomy and colostomy insertion 7 5 
Epilepsy 4 0 
Poisoning and overdose 3 1 
Poly trauma and Fractures 3 6 
Tumour and cancer 3 4 
Chronic obstructive pulmonary disease 2 1 
Motor vehicle accidents 2 0 
Overdose 2 1 
Cerebrovascular accident  1 1 
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Diagnosis as recorded on the ICU charts 2016  
(n=42) 
2017 
(n=48)  
Incision drainage 1 3 
Meningitis 1 1 
Rectal resection 1 0 
Renal dysfunction 1 1 
Respiratory distress  1 2 
Subarachnoid bleed 1 0 
Thyroid storm 1 0 
Cerebral Oedema 0 1 
Congenital heart failure 0 1 
Mastectomy 0 1 
Allergy  0 1 
Gastroenteritis 0 1 
Hemiarthroplasty 0 1 
Hepatitis syndrome 0 1 
Hydrocephalus 0 1 
Malaria 0 2 
Pneumonia 0 3 
Pulmonary Tuberculosis 0 1 
Stab wounds 0 2 
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Diagnosis as recorded on the ICU charts 2016  
(n=42) 
2017 
(n=48)  
Temporal burr hole (intracerebral) 0 1 
Vertebral fusion    0 1 
 
4.5. Length of stay in ICU 
The admitted patients in the two study periods had similar lengths of stay in the ICU. The 
median number of days in the ICU for both the 2016 and the 2017 study period was two but 
the interquartile range (IQR) for 2016 was (1-5) and for 2016 was a (1-4) day. Longest stay 
was 19 days and 22 days in 2016 and 2017 respectively. 
 
4.6. Antibiotic use in the ICU 
In reviewing the antibiotics used in the 2016 and 2017 (Figure 3), a greater percentage of 
patients were on antibiotics in 2017 (74.5%) than 2016 (67.4%). Overall, a total of 52 
antibiotics were used in 2016 and 56 in 2017. Out of the total antibiotics administered to the 
patients in the study period, 60% (n=31) in 2016 and 78% (n=44) in 2017 were kept as routine 
ward stock. Amoxicillin/clavulanic acid (42% in 2016 and 25% in 2017) and 
piperacillin/tazobactam (14% in 2016 and 16% in 2017) ranged among the most frequently 
prescribed antibiotic in the ICU during the 2016 and 2017 study period. Azithromycin (10% 
in 2016 and 14%) and ceftriaxone (6% in 2016 and 13% in 2017) also kept as ward stock 
antibiotics were frequently used during the study times.  
Colistin (2% in 2016), linezolid (4% in 2016 and 2% in 2017) and meropenem (5% in 2017) 
which required stricter measures by pharmacy for issue were used less frequently compared to 
other antibiotics.  
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Figure 3: Frequency of antibiotics prescribed in the ICU 
 
4.7. Number of antibiotics used per patient during ICU stay 
The number of antibiotics used per patient during their ICU stay is shown in Figure 4. The 
average antibiotic per patient in 2016 was 1.08 and in 2017 was 1.10. In both study periods no 
more than a total of four antibiotics were administered to a patient during their ICU stay. Most 
patients admitted in 2016 (44%) and 2017 (51%) were on one antibiotic during the ICU 
admission period.  
Concurrent use of antibiotics was seen in this study. In 2016, 10% (n=3) of patients on 
antibiotics were on two antibiotics concurrently and 2% (n=1) was on three antibiotics. In 
2017, 11% (n=4) of patients on antibiotics were on two antibiotics simultaneously and none 
was on three antibiotics. Although there were 7% more patients on antibiotics in the 2017 
study period, 8% more patients were on a single antibiotic during their ICU stay compared to 
the 2016 study time. A higher number of patients used a total of four antibiotics in 2016 
(8.7%) than 2017 (3.9%).  
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Figure 4: Percentage of antibiotics used per patient during the ICU stay 
 
4.8. Duration of antibiotics use 
The average duration of antibiotics used in the two study periods is summarized in Table 4. 
The days are presented as medians (IQR) because it was not normally distributed. 
In both study periods, the duration of antibiotic use varied amongst the antibiotics used. 
Piperacillin/tazobactam was used for a median number of four days (IQR 1-11 in 2017 and 
IQR 4-7 in 2017) while amoxicillin/clavulanic acid was used for a median number of two 
days in both 2016(1QR 1-4) and 2017(IQR 1-2) study periods. 
Ertapenem was used for a longer period in 2016 with a median number of five days (IQR 2-7) 
while in 2017 all patients received ertapenem for four days. While vancomycin was used for 
six days for one patient in 2016, vancomycin was used as a once off dose in 2017 for one 
patient in the ICU. 
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Table 4: Duration of antibiotic use 
 2016 2017 
Antibiotics Numbe
r 
Median (IQR) Numbe
r 
Median (IQR) 
Am/Cla 22 2 (1-4) 14 2 (1-2) 
Azit 5 2 (2-3) 8 3 (1.5-3.5) 
Cefa 1 1 5 3(1-5) 
Ceftaz 1 1 1 4 
Ceftri 3 3 (3-18) 7 3 (1-9) 
Cipro   1 2 
Clin 1 8   
Colix 1 1   
Etap 3 5 (2-7) 2 4 
Imip 4 5 (3.5-6) 4 2 (1.5-4) 
Linez 2 1.5 (1-2) 1 2 
Mero   3 1 
Ppt 7 4 (1-11) 9 4 (4-7) 
Tobra 1 1   
Vanco 1 6 1 1 
** Numbers without (IQR) was for a single patient or uniform range. 
 
4.9. Day in ICU when an antibiotic was started 
 The day, according to the patient‟s stay in ICU, that antibiotic treatment was initiated was 
documented as seen in Figure 5.  
 
 
33 
 
Reviewing all patients file studied, most of the patients, 63% (n=33) and 70% (n=39) 
admitted in the ICU in 2016 and 2017 respectively, were on antibiotic from day zero of their 
ICU stay. Amoxicillin/clavulanic acid was prescribed 91% (n=20) of the time from day zero 
in 2016 and in 2017 100% was started on day zero of ICU stay. Piperacillin/tazobactam was 
started 43% in 2016 from day zero and in 2017 100% was started on day zero.  
Carbapenems are restricted in HJH but 43% (n=3) in 2016 and 22% (n=2) in 2017 was started 
from day zero of ICU stay. Furthermore, the majority of azithromycin (60% n=3 in 2016 and 
43% n=3 in 2017) and ceftriaxone (67% n=2 in 2016 and 71% n=5 in 2017) was started on 
day zero. 
In comparison with other restricted antibiotics like colistin and linezolid which require the 
infectious disease consultant‟s signatures and a positive culture result to support pharmacy 
issue, all were started between days 1-3 of ICU stay.  
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b. (Day in ICU in which antibiotic was started in 2017) 
Figure 5: Day in ICU in which antibiotic was started (a) 2016 and (b) 2017 
 
4.10. Missed doses recorded for all antibiotics used 
A total of four missed doses were recorded for imipenem/cilastatin in both 2016 and 2017 
while in 2016 there was one linezolid dose missed.  
 
4.11. Antibiotic prescribed versus rationale for choice 
The rationale for prescribing antibiotics (empiric, prophylactic or definitive) was not indicated 
in all the patient ICU charts. This was determined retrospectively from reviewing the culture 
result and the day in which antibiotic was started. The terminology “presumed” was used to 
classify the different rationale because this could not be confirmed with the attending 
physician.  
Figure 6, describes the rational for which the different antibiotics were prescribed. It was 
noted that amoxicillin/clavulanic acid (100% n=22 in 2016 and 100% n=14 in 2017) and 
piperacillin/tazobactam (100% in 2016 and 100% in 2017) were presumed to be prescribed 
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empirically without a definitive culture result. Antibiotics used were considered empiric in 
2016 (83% n=43) and (10% n=5) were definitive while in 2017, 84 % (n=47) was considered 
empiric and 7% (n=4) was definitive. In comparison to the use of linezolid (100%), 
ciprofloxacin (100%) and colistin (100%) were started definitively following a positive 
culture result according to hospital formulary.  
 
a. (Rationale for antibiotics prescribed in 2016) 
   
b. (Rationale for antibiotics prescribed in 2017)   
Figure 6: Rationale for antibiotics prescribed (a) 2016 and (b) 2017. 
*PP = Presumed prophylactic   **PE= Presumed empiric   *** PD= Presumed definitive 
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4.11.1.  Rationale for initiation of antibiotic therapy  
Patients‟ overall antibiotic therapy was reviewed. Rationale of antibiotic therapy based on a 
culture result, a choice of antibiotics not based on culture and a not applicable group 
(antibiotic was either used as a once off dose or patients not on antibiotics) was studied and 
compared (Figure 7). It was noted that of the patients treated with antibiotics (2016: n=31 and 
2017: n=38) the majority of the patients were treated empirically (2016: n=19 and 2017: 
n=26) in 2016 and 2017 respectively. 
  
 Figure 7: Number of patient compared to decision made regarding antibiotic therapy 
**B- Decision to use antibiotics based on culture    
**N/B- Decision to use antibiotics not based on culture 
**N/A- Patients on a prophylactic dose or not on antibiotics. 
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4.12. Relationship between rationale for antibiotic choice and mean number of days 
stayed in the ICU 
Figure 8 describes the relationship between the rational for the choice of antibiotics and the 
number of days stayed in the ICU. It was seen that most patients in which antibiotics were 
chosen definitively had the longest stay in the ICU in both 2016 and 2017. Many patients who 
had a shorter stay in the ICU had empirical antibiotic therapy. The difference between the 
mean days in ICU across the decision to treat empirically and definitively are statistically 
different hence statistically significant. (2016: p = 0.0301; 2017: p = 0.0054). 
 
Figure 8: Relationship between rationale for choice of antibiotics compared to mean number 
of days stayed in the ICU 2016 (a) and (b) 2017  
*N/A-Not applicable patient on prophylactic dose or not on antibiotics. 
**N/B- Decision to use antibiotics not based on culture 
***BC- Decision to use antibiotics based on culture 
 
0
2
4
6
8
10
12
14
NA NB BC
N
u
m
b
er
 o
f 
d
ay
s 
in
 I
C
U
 
2016 2017Years 
 
 
 
38 
 
4.13. Doses of antibiotics used 
The total daily doses used in the two periods were similar except for the use of azithromycin, 
ertapenem and piperacillin/tazobactam. In 2016, azithromycin was prescribed as a daily dose 
of 500mg while in 2017 it was 500mg twice a day for all patients on azithromycin. Most of 
the patients were administered piperacillin/tazobactam as an infusion in the two study periods. 
In 2016, 57% (n=4) received a daily dose of 18g while 43% (n=3) was on a daily dose of 9g 
while in 2017, all the patients on piperacillin/tazobactam was on a daily dose of 9g. In 2016 
and 2017, the prescription of ertapenem followed a 1g dose per day for 60% (n=3) of patients 
and 40% (n=2) was on 2g per day. It was noted that dose range of 2g-4g a day dose was used 
for ceftriaxone in both 2016 and 2017. 
 
4.14. Culture and sensitivity pattern shown 
A total of 62 culture results and sensitivities were reviewed in 2016 and 43 in 2017. There 
were more cultures found for the patients receiving antibiotics in 2016 (n=62) compared to 
2017 (n=43). The sensitivity patterns of the microorganism that was isolated in the two-study 
periods are presented in Table 5.  
The five most frequently isolated pathogens in the both study period was Klebsiella 
pneumoniae (17%), Enterobacter cloacae (15%), Staphylococcus aureus (11%), Escherichia 
coli (9%) and Pseudomonas aeruginosa (6%). The ESKAPE pathogens which are namely 
Enterococcus faecum (4%), Staphylococcus aureus (11%), Klebsiella pneumoniae (11%), 
Acinetobacter sp (4%), Pseudomonas aeruginosa (6%) and Enterobacter cloacae (15%) 
which are virulent and develop multi resistance were found. Two extended beta lactamases 
producers which included Klebsiella pneumoniae and Enterobacter cloacae were isolated in 
the 2016 study period. There were also more isolates of Enterobacter cloacae isolated in the 
2016 (13%) study period than in the 2017 (2%). 
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There were 86% of Enterobacter cloacae isolated in both 2016 and the 2017 study period 
which were sensitive to carbapenems and resistant to co-trimoxazole and ceftriaxone aside 
one isolate which was resistant to all antibiotics tested for and colistin was suggested by the 
microbiology laboratory.  
Amongst the Staphylococcus aureus isolated, 60% in both study periods was sensitive to 
cloxacillin, 40% was sensitive to only vancomycin. There was 70% Escherichia coli isolate 
which were not sensitive to amoxicillin/clavulanic acid.  
 Acinetobacter baumanii (n=2) was isolated in both years with the 2016 isolate being resistant 
to ciprofloxacin, amikacin and sensitive only to colistin but the isolate in 2017 was sensitive 
to ciprofloxacin and amikacin.  
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Table 5: Isolates and resistance patterns  
Isolates 2016 2017 
Number  of 
isolates from 
different 
patients 
Sensitive to Resistant to Number of 
isolates from 
different 
patients 
Sensitive to Resistant to 
Acinetobacter 
baumanii 
1 Colix Co-tri,Cipro,PPT, Mero, 
Imip,amik 
 
1 Cipro, Amik Amp-pen, PPT, Co-
tri, Mero, Cefep 
 Burkholderia 
cepacia 
   1 Co-tri,Ceftri PPT, Genta, Cefep, 
Amik, Imip, Colis, 
cipro 
Enterococcus 
avium 
3 Etap 
Imip 
Am/Cla, Co-tri, PPT,Cipro, 
Ceftri, 
Cefep 
   
Enterococcus 
gallinarum 
1 Linez     
Enterococcus 
faecium 
1 Vanco Amp-Amo 1 Vanco Amo and Amp 
Enterococcus 
faecalis 
   1 Amo  
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Isolates 2016 2017 
 Number  of 
isolates from 
different 
patients 
Sensitive to Resistant to Number of 
isolates from 
different 
patients 
Sensitive to Resistant to 
Enterobacter 
cloacae 
 
 
4 Etap, Imip Co-tri,Amp-cla, Amp-amo, 
Ceftri cefuroxime 
1 Imip, mero Co-tri, Amo-Amp, 
Cefep, Ceftri, Cefu 
cefuroxime 
1 Etap,Cefep, 
cipro 
Co-tri, Amo-cla,Ceftri, 
cefuroxime 
   
1 None 
(ESBL) 
Co-tri, Amp-cla, Amp-amo 
Ceftri, Cefuroxime, PPT 
   
Escherichia coli 1 Amox-cla, 
Etap, Imip 
Amp-amo 
 
1 Mero, Imip Am/Cla, Amp-Pen, 
Co-tri, Ceftri 
1 Imip Co-tri, Amp-amo, Cipro 
 
   
1 Imip, ertap Genta, Co-tri, Amp-amo, Amo-
cla, 
Cipro, Ceftria, cefep 
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Isolates 2016 2017 
 Number  of 
isolates from 
different 
patients 
Sensitive to Resistant to Number of 
isolates from 
different 
patients 
Sensitive to Resistant to 
Klebsiella 
pneumoniae 
1 Ceftri PPT, Amp-amo, Co-tri 2 Am/Cla 
Co-tri, Ceftri 
 
1 Am/Cla Amp-Pen 
 
   
3 Etap 
Imip 
Am/Cla, Co-tri, PPT,Cipro, 
Ceftri, 
Cefep 
   
1 None Amp-Amo, Amo-clav, Ceftria 
Cefep, Tobra, PPT, Mero 
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Isolates 2016 2017 
Number  of 
isolates from 
different 
patients 
Sensitive 
to 
Resistant To Number of 
isolates from 
different 
patients 
Sensitive to Resistant to 
Haemophilus 
influenzae 
   1 Amo-cla Co-tri 
 
Pseudomonas 
aeruginosa 
1 None Amp-Amo, Amo-clav, Ceftria 
Cefep, Tobra, PPT, Mero 
1 Ceftri, Imip 
Cipro 
PPT, Tigercycline 
1 None Amp-Amo, Amo-clav, Ceftria 
Cefep, Tobra, PPT, Mero 
  Amp-pen  and  Clox 
Proteus mirabilis 1 Am/Cla, 
Co-tri 
    
Proteus vulgaris 1 Etap, 
imip 
Cefazo, Co-tri, Amp-amo, 
cefuroxime 
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Isolates 2016 2017 
Number of 
isolates from 
different 
patients 
Sensitive 
to 
Resistant To Number of 
isolates from 
different 
patients 
Sensitive to Resistant to 
Staphylococcus 
aureus 
1 Clox Genta, Co-tri, Amp-Pen, Amo-
cla, 
Cipro, Ceftria, cefep 
2 
 
Clox 
 
PPT, Co-tri, 
Amp,Pen 
   2 Vanco Amp-pen  and  Clox 
Staphylococcus 
epidermidis 
1 Vanco Pen-Amp, Clox, Co-tri, Azit, 
PPT 
 
1 Vanco Clox, Amp-Pen 
Streptococcus  
pyogenes 
3 Pen     
Streptococcus  
anginosus 
1 Pen     
Stenotrophomonas 
spp 
   1 Co-tri  
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4.15. Infection markers performed 
In the two study periods CRP was ordered every day for each patient admitted in the ICU. 
Procalcitonin on the other hand was only done for one patient in 2016 and for two patients in 
2017.  
 
4.16. Summary 
From the results, it was seen that amoxicillin/clavulanic acid and piperacillin/tazobactam were 
the most used antibiotics in the two-periods studied. Antibiotics kept in the ward as routine 
ward stock were started mostly from day zero of patient‟s admission compared to restricted 
antibiotics. Restricted antibiotics were used infrequently in comparison to non-restricted 
antibiotics. It was also noted that the average length of stay in the HJH ICU was two days. 
Duration of antibiotic varied widely. Furthermore, the rationale for antibiotic use was based 
mostly empirical rather than definitive in the two periods studied. Decisions which were 
based definitively were seen more in patients with longer length of stay in the ICU. 
The next chapter is the discussion. 
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CHAPTER 5:  DISCUSSION 
5.1. Introduction 
Although drug utilization studies have been done in South Africa (Paruk et al., 2012) to 
investigate the usage pattern of antibiotic in the various ICUs, however there have been no 
studies such as this in HJH ICU. Operational research such as this will make an important 
contribution to this hospital.  
Clinicians are pressured to prescribe antibiotic for the critically ill in the ICU even when not 
necessary (Labuschagne et al., 2016; Sarin et al., 2013; Williams et al., 2011). To monitor 
judicious use of antibiotics, individual hospital antibiotic prescription monitoring is 
advantageous (Suryawanshi et al., 2015). 
Although antibiotic therapy needs to be given without delay in the ICU, considering 
inconclusive radiological findings and delay in microbiology results leaves the treating 
clinicians no confirmation hence broad-spectrum antibiotic is chosen frequently and most 
often inappropriately (Broyles, 2017). Notwithstanding critical care and immediate need for 
decision, antibiotic stewardship principles should be adhered to before starting antibiotic 
therapy (Kolak, 2010; Zhang and Singh, 2015). 
 
5.2. Utilization pattern of Antibiotic in the ICU 
The ICU is known for high antibiotics use (Williams et al., 2011; Sarin et al., 2013). In this 
study, 67.4% in 2016 and 74.5% in 2017 of patients admitted in the ICU received antibiotics. 
Similar range to this HJH study, a range of 76% was reported by Hanssens et al. (2005). 
However, higher values ranging from 80% - 95% were seen in the studies by Anand et al. 
(2016), John et al. (2011), Williams et al. (2011) and Patanaik et al. (2015). This is suggestive 
that antibiotics are frequently used in the ICU. 
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 Furthermore, lower ranges compared to the result achieved in this study between 30-57.5% 
were reported in studies by Shankar et al. (2005) and Usluer et al. (2005). The difference 
could be due to the different population studied as well as the type and speciality of hospitals 
where the studies were performed. Antibiotic prescription pattern differs from hospital to 
hospital and from one ward to another.  
Piperacillin/tazobactam and amoxicillin/clavulanic acid which are penicillin antibiotics were 
the most common antibiotics prescribed in the HJ ICU. This is similar to a study done by 
Anand et al. (2016) in India where piperacillin/tazobactam and amoxicillin/clavulanic acid 
were amongst the five most prescribed antibiotics in the ICU. Likewise, penicillin antibiotics 
was the most used antibiotics in a study by Shankar et al. (2005) in Nepal. The antibiotic 
usage trend in HJH could be attributed to penicillin antibiotics being one of the first line 
antibiotics on the hospital formulary. In contrast to this study Williams et al., (2011) reported 
the 3
rd
 generation cephalosporins, meropenem and levofloxacin, John et al (2011) was 
cephalosporins and aminoglycosides and Badar and Navale (2012) reported cefotaxime as the 
most prescribed antibiotics in the ICU. 
In this study, lesser utilization of linezolid, colistin, meropenem, and vancomycin was 
documented, and this was comparable to results found by Anand et al. (2016) and Molayi et 
al. (2018). Restrictive protocols have been used to reduce antibiotic consumption (Vitrat et 
al., 2014). In this study, restricted antibiotics were used to a lesser extent than those kept in 
the ward as routine ward stock.  
Additionally, the duration of antibiotics as seen in this study varied widely from one day to 18 
days. This is in line with a study by Chin et al. (2010) which reported a wide range of 1-42 
days. 
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Missed doses were not infrequently noted in this study. Missing of antibiotic doses could lead 
to sub therapeutic levels increasing the emergence of resistant pathogens (Alexander et al., 
2008). 
An average of one antibiotic was used per patient in this study. Similar range of 1.73-1.74 
was seen in the studies by Amit (2013) and Anand et al. (2016). Higher number of 2.5-2.74 of 
antibiotics per person was seen in the studies done by Patel et al. (2013) and Khan et al. 
(2013). Even a higher average of three was reported in a study done in South Africa ICUs by 
Paruk et al. (2012). 
At most three antibiotics were used concurrently. In both years, an average of 11% (n=7) of 
two antibiotics and 2 %( n=1) of three antibiotics were concurrently used. In comparison with 
the study done by Paruk et al., (2012), concurrent use of antibiotics ranged from 2-10 
antibiotics.  
 
5.3. Empiric, definitive and prophylactic use of antibiotics  
Clinicians face challenges in finding the balance between adequate empiric cover and at the 
same time reducing selection pressure for resistant strain (Eliopoulos et al., 2003; Zilahi et al., 
2016). The overuse of empiric antibiotic coverage is linked to the emergence of antibiotic 
resistance, yet optimal empiric cover is linked with reduced mortality of patients with severe 
sepsis and septic shock (Eliopoulos et al., 2003; Ferrer et al., 2014).  
Result from this study showed that the most empiric selected antibiotics in the ICU were 
amoxicillin/clavulanic acid and piperacillin/tazobactam. In line with this study are studies 
done by Thomas et al. (2015) and Chin et al. (2010) which reported piperacillin/tazobactam 
was one of the frequently used empiric antibiotic.  
 
 
49 
 
Although in this study all piperacillin/tazobactam initiation was empirical, in the study done 
by Chin et al., (2010) 32.1% of piperacillin/tazobactam was empiric. Of note, vancomycin 
was one of the frequently used antibiotics in a study by Thomas et al., (2015) but in this 
study, vancomycin was one of the least used antibiotics. Hence broad-spectrum antibiotics are 
frequently chosen as empiric therapy in the ICU. Further, the HJH hospital guideline suggest 
the use of broad spectrum antibiotic followed by de-escalation to a narrow spectrum when 
culture results are received. This important principle of stewardship could not be confirmed in 
our study as the length of stay was short and broad-spectrum antibiotics was continued 
mostly.  
Total number of patients treated empirically in this study was an average of 63%. Comparable 
ranges were seen in the studies by Chin et al. (2010) which reported 68% and Shrikala et al. 
(2010) who reported 63%. In line with these two studies, the antibiotics prescribed in the HJH 
ICU are mostly empiric. Therefore, necessitating the monitoring of antibiotics used 
empirically and implementation of stewardship principles.  
An average of 8% (n=8) of patients were treated prophylactically. This is lower than the study 
done by Malacarne et al., (2004) which reported 31%. The reason for the disparity in the 
numbers of prophylactic cases seen in the study by Malacarne et al., (2004) and this study 
could be that HJH has a smaller ICU and also their study was a multi-centre study. 
Furthermore, in contrast to this study which used 86% of first-generation cephalosporin 
(cefazolin) prophylactically, the study done by Malacarne et al., (2004) reported a 42% 
prophylactic use of a third-generation cephalosporin. Altogether, the reviewed studies confirm 
more antibiotics are prescribed empirically in the ICU (Chin et al., 2010; Shrikala et al., 
2010). 
Culture results from the laboratory does not often become available within 24 to 72 hours as 
supported by Vitrat et al, (2014) and Leekha et al, (2011). This pressures the clinicians to 
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choose antibiotics empirically. This was also seen in this study at HJH as the majority of 
definitive antibiotic therapy was seen in patients with longer stay in the ICU. 
 
5.4. Length of stay 
The average length of stay reported in this study was two days. Comparable range of 3.3 was 
seen in the studies by Hunter et al. (2014). However, longer ranges of 4.5-5.75 was seen in 
study by Agrawal et al. (2017), Biswal et al. (2006) and John et al. (2011) and in a local study 
conducted by Hanekom et al. (2006) the length of stay was 6 days. The reason for the 
variation could be varied diseases seen in the different studied population and also in HJH 
ICU, there are limited ICU beds available and patients once stable are often moved to general 
ward. 
 
5.5. Diagnosis 
The reason for antibiotic therapy was not indicated on the majority of the ICU chart in both 
2016 and 2017 study periods. The diagnosis on admission into the ICU remained the 
diagnosis on all the patients‟ ICU chart. One of the core elements of antibiotic stewardship 
principles as sited by Pollack and Srinivasan (2014) is the documentation of the reason of 
antibiotic initiation. This will help to monitor and implement better policies to support 
judicious antibiotic use. Therefore, linking diagnosis to the antibiotics used was not attainable 
in this retrospective record review study. 
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5.6. Infection markers utilized 
Issuing effective antibiotics is the gold standard within an hour of sepsis to reduce morbidity. 
Culture takes 24-48 hours and many times more, infection markers are advantageous in the 
ICU to initiate antibiotics and reduce the risk bad health outcomes (Vitrat, 2014).  
In this study, CRP was the most frequently used infection marker which was done every day 
for the patients as routine and this is in line with a study done by Povoa et al. (2006). They 
concluded that with a sensitivity of 92.1 and a specificity of 82.1, CRP is useful in the 
prediction of infection in the ICU. The PCT was done rarely in the two periods of study. 
However, studies comparing the use of PCR and CRP in predicting infection found that the 
PCR was better in accuracy and in identification of severity of sepsis (Markanday, 2015; 
Nargis et al., 2014). Furthermore, the PCR assay is more expensive than the CRP and this 
poses a financial challenge. 
 
5.7. Microorganism isolated and sensitivities 
In this study the most isolated microorganisms were Klebsiella pneumoniae (17%), 
Enterobacter cloacae (15%), Staphylococcus aureus (11%), Escherichia coli (9%) and 
Pseudomonas aeruginosa (6.3%). Refer to Table 5, Enterobacter cloacae, Klebsiella 
pneumoniae, Pseudomonas aeruginosa and  Escherichia coli which were amongst the 
commonly isolated in this study was supported by studies done by  Radji et al. (2011),Tran et 
al. (2017) and Greatorex and Oosthuize (2015). 
Comparing this study to a study done in a Canadian ICU by Zhanel et al. (2008), 
Haemophilus influenzae (7.9%) was one of the ten frequently isolated pathogens. In this 
study, Haemophilus influenza was infrequently isolated (2%) and was only present in the 
2017 time period. This could be attributed to the timing of the study.  
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The susceptibility of Klebsiella pneumoniae showing resistance to ceftriaxone was reported 
by Radji et al. (2011) to be 75.7%. This was similar to this study which was 75%. Another 
study done in an ICU in Southern Italy by Agodi et al. (2015) reported 87% which was higher 
than that documented in this study. It is clear from these studies presented that pathogens and 
their susceptibility in different ICUs vary widely. 
Even though there were similarities in sensitivity to antibiotics shown by isolates of the same 
genre in both study periods, there were antibiotic sensitivity disparities found within similar 
isolates. For example, 50 % of Klebsiella pneumoniae isolated was sensitive to 
amoxicillin/clavulanic acid, 38% was resistant yet sensitive to carbapenems and 13% was not 
sensitive to any antibiotics tested. This is supported by literature in articles written by 
Chaudhry and Prajapat (2017) and Sulaiman (2016).  
Overall, it is important to understand clearly the genre and sensitivity of the microorganism in 
question to enable appropriate choice of antibiotics and improve adequate therapy while 
reducing antibiotic resistance. Knowledge of the present susceptibility patterns also can be 
used to ascertain the influence of antibiotic stewardship strategies that have been implemented 
(Chunnilal et al., 2015; Goff, 2011). 
 
5.8. Summary 
Based on the findings of this study, broad spectrum antibiotics were chosen frequently in the 
ICU and comparable to studies from abroad. More antibiotics are prescribed empirically 
compared to definitive antibiotic therapy in the ICU and this is in line with the literature. The 
average number of antibiotics used in this study was below the recorded average of the studies 
mentioned. The length of stay in the HJH ICU was short in comparison to the studies cited. 
The measures in place restricting the use of specific antibiotics seem effective. The two 
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infection markers used in the ICU during this study was the PCR and the CRP. The PCR 
which is better than the CRP was used less frequently. 
There are different patterns of antibiotic utilization seen across the world. Also, the pathogens 
and their susceptibilities vary from hospital to hospital. Considering the difference, it is 
paramount that each hospital monitors their individual antibiotic usage to enable an informed 
antibiotic stewardship intervention. 
The next chapter is conclusion. 
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CHAPTER 6: CONCLUSION 
6.1. Introduction 
This chapter showcases the conclusion of this study carried out for two months in Helen 
Joseph intensive care unit. This is then followed by the study limitations and 
recommendations. 
 
6.2. Conclusion  
In conclusion the results obtained from this study shows the importance of documenting the 
usage of antibiotics especially as the hospital embarks on improving antibiotic stewardship. 
Notably, the majority of patients admitted in the ICU were on antibiotics and the rationale for 
choice was mostly empiric. The most frequently used antibiotics were amoxicillin/clavulanic 
acid and piperacillin/tazobactam. It was also eminent in our study that restriction of 
antibiotics improves utilization as antibiotics which required lesser authorization to release 
from the dispensary were used more frequently than antibiotics requiring stricter 
authorization. This study further found that the length of stay in the HJH ICU is short and also 
concurrent use of antibiotics was low. 
This study concluded that if there are no appropriate interventions, same practices will 
continue. In both study times, similarities were found in antibiotics prescribed, doses, 
rationale for antibiotic choice and the day on which the antibiotic was started. Also indicating 
the reason for antibiotic prescription is not generally practiced. This study likewise revealed 
the susceptibility pattern of microorganisms isolated in the study period and concluded that 
susceptibility of the same genre of microorganism can differ.  
The ICU has major advantages in the pursuit for antibiotic stewardship. The closely 
monitored and supervised environment offers the chance to optimize antibiotic delivery, track 
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the outcome, and make early decisions concerning escalation or stopping of antibiotic 
therapy.  
This study informs on the antibiotic use, the dose and the frequencies of antibiotics used on 
the patients in the two-study period and as well the rationale for which these antibiotics were 
chosen. This affords baseline data from the HJH ICU which is available for further studies 
and developing strategies to improve antibiotic use. 
 
6.3. Study limitation 
The following study limitations need to be noted: 
1. Missing data 
 Missing data on the ICU charts made the data collection more difficult. 
 The reason for antibiotic initiation was not regularly documented. 
2. No electronic information backup 
 All information written on the chat was manual and there was no electronic 
back up of information should chart not be found. This further reduced the 
studied population. 
3. Time and resources constraint 
 Period studied was short and only provides a snapshot to the usage of 
antibiotics in the HJH ICU ward.   
 
6.4.  Recommendation from this study 
Following the review of data from this study, the following recommendation emerged which 
could help in improving antibiotic utilization. 
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 The reason for antibiotic initiation and all information relating to antibiotic use 
should be documented on the ICU charts when prescribing antibiotics. It also 
allows for the pharmacist to advise and hence ensure better antibiotic management. 
 The time when antibiotics are prescribed needs to be noted on the ICU chart. This 
will help ensure that the dose is administered within an hour. 
 Improvements need to be made to insure all files are archived. A signing system 
could be implemented to track when files are received and removed. 
 Since the ICU admits very sick patients, a fast track should be created for the 
patients admitted in the ICU by the laboratory and the pharmacy. This will ensure 
the ICU gets timely results regarding the patients and this will help to make 
accurate decisions on antibiotic choice. The scripts coming to the pharmacy from 
the ICU should be analysed by a clinical pharmacist and dispensed timeously. The 
clinical pharmacist should be responsible to ensure all the restrictive rules have 
been adhered to by the clinician and ensure appropriate dose, frequency and 
duration of the antibiotics. The clinical pharmacist will also need to do ward 
rounds in the ICU ensuring the doses have been dispensed to the patients 
according to the clinicians‟ orders and to make recommendations and interventions 
to ensure a prudent use of antibiotics and an overall functional antimicrobial 
stewardship plan. 
 
6.5. Recommendation for future studies 
Since this study has shown similarities to the common practice which is not advantageous in 
curbing antibiotic use, further studies need to be carried out to ascertain the effect of 
implementing an antibiotic prescribing chart.  
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6.6. Summary 
The core element of antibiotic stewardship is in documentation of information relating to the 
use of antibiotics. This study provided information regarding the utilization of antibiotics in 
the HJH ICU for the period studied. Without any intervention implemented, there were more 
similarities than there were differences in the utilization pattern seen in both time. 
Furthermore, to ensure that effective antibiotic stewardship program is implemented, 
intervention informed by utilization studies is central to its success. 
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Appendix 5: Restricted antibiotics issued per patient in Helen Joseph Hospital ICU 
 
Antibiotics Route Hospital Formulary requirement/Restrictions 
Amoxicillin/clavulanic acid 1g  PO None 
Ceftazidime 1g   IV Any consultant signature 
Cefepime 1g/2g  IV Any consultant signature 
Ciprofloxacin 400mg/200mg IV Sensitivity result + consultants signatures 
Clindamycin 600mg  IV None 
Colistin 1mu IV Infectious disease consultant signature + sensitivity 
result  
Ertapenem 1g IV Any consultant signature   
Imipenem 500mg  IV Any consultant signature 
Linezolid 600mg  IV/PO Infectious disease consultant signature  
Meropenem 500mg/1g IV Infectious disease consultant signature + sensitivity 
result + motivation 
Vancomycin  0.5g/1g IV Any consultant signature 
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Appendix 6: Antibiotics kept as ward stock in Helen Joseph Hospital ICU 
 
Amoxicillin/clavulanic 375mg PO 
Amoxicillin/clavulanic 1,2g  IV 
Azithromycin  IV/PO 
Benzathine penicillin IV 
Benzyl penicillin PO 
Benzyl penicillin IV 
Cefazolin 1g IV 
Ceftriaxone 1g IV 
Ciprofloxacin 500mg PO 
Cloxacillin 250mg/500mg IV 
Co-trimoxazole 480mg IV/PO 
Doxycycline 100mg  PO 
Gentamicin 80mg IV 
Kanamycin  IV 
Phenoxymethypenicillin with vitamin k PO 
Piperacillin/tazobactam 4.5g IV 
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